MENS — Jyong Biotech Ltd. Ordinary Shares

MENS closed at $1.77 (0.00%) on Oct 26, 2026. Float: 31.1M shares. Latest SEC filing: 20-F on May 15, 2026.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for MENS in the TickerWise workspace.

Jyong Biotech Ltd. is a Taiwan-based biotech firm focused on developing and commercializing plant-derived drugs targeting urinary system diseases. The company operates through its subsidiaries—Health Ever Bio-Tech, Genvace, and others—working on drug candidates like MCS‑2 (for BPH) currently in Phase III, PCP (for prostate cancer) in Phase II, and IC in pre-clinical stages

Company profile

• Sector: Healthcare
• Industry: Biotechnology
• Country: TW
• Exchange: NASDAQ
• Employees: 31
• Website: https://www.jyongbio.com/

Latest SEC filings for MENS

• 2026-05-1520-F
• 2026-04-29NT 20-F
• 2026-02-066-K
• 2026-01-096-K

Related companies

• VRTX — Vertex Pharmaceuticals Incorporated
• MRNA — Moderna, Inc.
• REGN — Regeneron Pharmaceuticals, Inc.
• ARGX — argenx SE
• ALNY — Alnylam Pharmaceuticals, Inc.
• INSM — Insmed Incorporated
• RVMD — Revolution Medicines, Inc.
• UTHR — United Therapeutics Corporation

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.